Literature DB >> 15735157

Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.

J Haapasalo1, A Mennander, P Helen, H Haapasalo, J Isola.   

Abstract

BACKGROUND: Astrocytic tumours, the most common gliomas, are often classified intraoperatively using standard morphological staining. The final diagnosis and grading of gliomas on paraffin wax sections is often assisted by Ki-67 immunohistochemistry, but standard immunostaining protocols take too long to be used intraoperatively. AIMS: To investigate a new rapid Ki-67 immunohistochemical test for its use in an intraoperative setting.
METHODS: The new Ki-67 immunostaining (Ultrarapid-Ki67) method on frozen sections can be carried out in 10 minutes. Thirty four pilocytic and diffuse astrocytomas were immunostained by rapid Ki-67 and results were compared with corresponding MIB-1 staining, histological grading, and prognosis.
RESULTS: The staining protocol was practical to perform and the results were morphologically and quantitatively indistinguishable from those after immunostaining with MIB-1, an antibody recognising Ki-67 in paraffin wax embedded tissue. A comparison of Ultrarapid-Ki67 and MIB-1 immunostaining of paraffin wax sections showed almost identical quantitative correlation in astrocytic gliomas (r = 0.916; p<0.001). The Ultrarapid-Ki67 indices (percentage of positive cells) of low grade (I/II) astrocytomas ranged from 0% to 6.1%, whereas those of representative high grade (III/IV) tumours were significantly higher (range, 5.6-45%; p<0.001). The best prognostic cutoff point for Ultrarapid-Ki67 was 7.5%, which divided diffuse grade II-IV astrocytomas into significantly differing subsets (p = 0.0008).
CONCLUSION: Ultrarapid-Ki67 immunostaining is a useful adjunct to morphological diagnosis and grading of astrocytic tumours, and as a fast test (approximately 10 minutes for staining plus three to four minutes for scoring), it could be used in routine intraoperative diagnosis of gliomas and other neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735157      PMCID: PMC1770597          DOI: 10.1136/jcp.2004.018606

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  A new rapid immunohistochemical staining technique using the EnVision antibody complex.

Authors:  U Kämmerer; M Kapp; A M Gassel; T Richter; C Tank; J Dietl; P Ruck
Journal:  J Histochem Cytochem       Date:  2001-05       Impact factor: 2.479

2.  Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

Authors:  P K Sallinen; S L Sallinen; P T Helén; I S Rantala; E Rautiainen; H J Helin; H Kalimo; H K Haapasalo
Journal:  Neuropathol Appl Neurobiol       Date:  2000-08       Impact factor: 8.090

3.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

4.  Improvement of the rapid immunoperoxidase staining method for intraoperative pathological diagnosis of pancreatic cancer using microwave irradiation.

Authors:  T Ichihara; A Nakao; Y Suzuki; J Sakamoto; T Nonami; A Harada; H Nagura; H Takagi
Journal:  J Surg Oncol       Date:  1989-11       Impact factor: 3.454

5.  Application of a quick immunoenzymatic labeling as an adjunct to frozen-section diagnosis.

Authors:  S S Tabibzadeh; K D Shah
Journal:  Am J Clin Pathol       Date:  1989-01       Impact factor: 2.493

6.  Protocol for ultrarapid immunostaining of frozen sections.

Authors:  T Richter; J Nährig; P Komminoth; J Kowolik; M Werner
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

7.  Cellular proliferation in pilocytic and diffuse astrocytomas.

Authors:  C Giannini; B W Scheithauer; P C Burger; M R Christensen; P C Wollan; T J Sebo; P A Forsyth; C J Hayostek
Journal:  J Neuropathol Exp Neurol       Date:  1999-01       Impact factor: 3.685

8.  Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.

Authors:  P K Sallinen; H K Haapasalo; T Visakorpi; P T Helén; I S Rantala; J J Isola; H J Helin
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996

9.  Enhanced polymer one-step staining (EPOS) for proliferating cell nuclear antigen (PCNA) and Ki-67 antigen: application to intra-operative frozen diagnosis.

Authors:  Y Tsutsumi; A Serizawa; K Kawai
Journal:  Pathol Int       Date:  1995-02       Impact factor: 2.534

10.  Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.

Authors:  K Onda; R L Davis; M Shibuya; C B Wilson; T Hoshino
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

View more
  8 in total

1.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

2.  Low-grade gliomas in children: single institutional experience in 198 cases.

Authors:  Magda Garzón; Gemma García-Fructuoso; Mariona Suñol; Jaume Mora; Ofelia Cruz
Journal:  Childs Nerv Syst       Date:  2015-07-09       Impact factor: 1.475

3.  Proliferating progenitor cells: a required cellular element for induction of ischemic tolerance in the brain.

Authors:  Samaneh Maysami; Jin Quan Lan; Manabu Minami; Roger P Simon
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-05       Impact factor: 6.200

4.  Primary gliomatosis cerebri involving gray matter in pediatrics: a distinct entity? A multicenter study of 14 cases.

Authors:  Céline Chappé; Laurent Riffaud; Catherine Tréguier; Béatrice Carsin-Nicol; David Veillard; Dan Cristian Chiforeanu; Jacques Grill; Didier Frappaz; Nicolas André; Fréderic Millot; Matthieu Vinchon; Nicolas Sirvent; Christine Edan
Journal:  Childs Nerv Syst       Date:  2013-01-10       Impact factor: 1.475

5.  The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.

Authors:  Alessandro Del Gobbo; Valentina Vaira; Lucia Ferrari; Carlo Patriarca; Andrea Di Cristofori; Dario Ricca; Manuela Caroli; Paolo Rampini; Silvano Bosari; Stefano Ferrero
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

6.  Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections.

Authors:  Saska Brajkovic; Diego G Dupouy; Laurence de Leval; Martin Am Gijs
Journal:  Lab Invest       Date:  2017-05-29       Impact factor: 5.662

7.  Intravoxel Incoherent Motion Diffusion-Weighted Imaging and 3D-ASL to Assess the Value of Ki-67 Labeling Index and Grade in Glioma.

Authors:  Jian Zhou; Huafeng Li; Xiaoming Ma; Miao Jin; Xin Meng; Guangfeng Zhang
Journal:  Scanning       Date:  2022-08-31       Impact factor: 1.750

Review 8.  The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Daniel P Cahill; Andrew E Sloan; Brian V Nahed; Kenneth D Aldape; David N Louis; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.